Purple Biotech (PPBT)
(Delayed Data from NSDQ)
$5.65 USD
-0.35 (-5.92%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $5.65 +0.01 (0.09%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Purple Biotech Ltd. Sponsored ADR (PPBT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$126.50 | $220.00 | $33.00 | 2,008.33% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Purple Biotech Ltd. Sponsored ADR comes to $126.50. The forecasts range from a low of $33.00 to a high of $220.00. The average price target represents an increase of 2% from the last closing price of $6.00.
Analyst Price Targets (2 )
Broker Rating
Purple Biotech Ltd. Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, two are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/11/2024 | H.C. Wainwright & Co. | Emily Bodnar | Strong Buy | Strong Buy |
3/7/2024 | Chardan Capital Markets | Daniil Gataulin | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 2 |
Average Target Price | $126.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -1.20 |
PPBT FAQs
Purple Biotech Ltd. Sponsored ADR (PPBT) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Purple Biotech Ltd. Sponsored ADR (PPBT) is $126.50. The current on short-term price targets is based on 1 reports.
The forecasts for Purple Biotech Ltd. Sponsored ADR (PPBT) range from a low of $33 to a high of $220. The average price target represents a increase of $2138.94 from the last closing price of $5.65.
The current UPSIDE for Purple Biotech Ltd. Sponsored ADR (PPBT) is 2138.94%
Based on short-term price targets offered by two analysts, the average price target for Purple Biotech Ltd. Sponsored ADR comes to $126.50. The forecasts range from a low of $33.00 to a high of $220.00. The average price target represents an increase of 2% from the last closing price of $6.00.